CX3CR1, a TNF target found to be down-regulated by SB225002 treatment, has been implicated in chronic lymphocytic leukemia attraction and adhesion to bone marrow stromal cells [30]. Here, TNF is linked to B-cell chronic lymphocytic leukemia.